Growth Metrics

Teva Pharmaceutical Industries (TEVJF) Amortization - Intangibles (2016)

Historic Amortization - Intangibles for Teva Pharmaceutical Industries (TEVJF) over the last 6 years, with Q4 2016 value amounting to $170.0 million.

  • Teva Pharmaceutical Industries' Amortization - Intangibles fell 1237.11% to $170.0 million in Q4 2016 from the same period last year, while for Dec 2016 it was $876.0 million, marking a year-over-year decrease of 1274.9%. This contributed to the annual value of $170.0 million for FY2016, which is 1237.11% down from last year.
  • Teva Pharmaceutical Industries' Amortization - Intangibles amounted to $170.0 million in Q4 2016, which was down 1237.11% from $194.0 million recorded in Q4 2015.
  • Teva Pharmaceutical Industries' 5-year Amortization - Intangibles high stood at $298.0 million for Q4 2013, and its period low was $170.0 million during Q4 2016.
  • Moreover, its 5-year median value for Amortization - Intangibles was $268.0 million (2014), whereas its average is $244.9 million.
  • In the last 5 years, Teva Pharmaceutical Industries' Amortization - Intangibles skyrocketed by 996.31% in 2013 and then plummeted by 2049.18% in 2015.
  • Over the past 5 years, Teva Pharmaceutical Industries' Amortization - Intangibles (Quarter) stood at $271.0 million in 2012, then grew by 9.96% to $298.0 million in 2013, then fell by 18.12% to $244.0 million in 2014, then decreased by 20.49% to $194.0 million in 2015, then decreased by 12.37% to $170.0 million in 2016.
  • Its Amortization - Intangibles stands at $170.0 million for Q4 2016, versus $194.0 million for Q4 2015 and $244.0 million for Q4 2014.